NCT06618534View on ClinicalTrials.gov

Azithromycin for Meningococcal Carriage

PHASE2RecruitingINTERVENTIONAL
Enrollment

1,120

Participants

Timeline

Start Date

November 12, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Meningococcal Infections
Interventions
DRUG

Azithromycin

A standard dose of azithromycin (500 mg) will be delivered by oral route.

Trial Locations (1)

30030

RECRUITING

Hope Clinic of the Emory Vaccine Center, Decatur

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Georgia Department of Public Health

UNKNOWN

lead

Emory University

OTHER